BioTime Announces Joint Hypothermic Medicine Study With Argonne National Laboratory
EMERYVILLE, Calif.--(BUSINESS WIRE)--BioTime, Inc. (OTCBB:BTIM - News) and Argonne National Laboratory today announced that they intend to engage in a cooperative research program in the field of therapeutic hypothermia. BioTime and Argonne have each developed complementary technologies in the field with potential applications in stroke, heart attack, and trauma patients.